Print Page

Products found to contain undeclared medicines

The United States: Bee Thin: Public Notification - Undeclared Drug Ingredient Sibutramine
FDA is advising consumers not to purchase or use Bee Thin. FDA laboratory analysis confirmed that Bee Thin contains sibutramine. Sibutramine is a controlled substance that was removed from the US market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life-threatening ways, with other medications a consumer may be taking. Bee Thin is a product promoted and sold for weight loss on various websites, and possibly in some retail stores. Consumers are advised not to purchase or use Bee Thin.

Please refer to the following website in FDA for details:

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/ Tuesday, November 25, 2014
Issued at HKT 13:00